Showing results (1761-1770 of 1,877) with videos related to
Sort By:
Pageof 188
Nature Communications|April 23, 2020
Timing the initiation of multiple myelomaEven H Rustad, Venkata Yellapantula, Daniel Leongamornlert, et al.Tissue Antigens|March 25, 2010
Analysis of the HLA population data (AHPD) submitted to the 15th International Histocompatibility/Immunogenetics Workshop by using the Gene[rate] computer tools accommodating ambiguous data (AHPD project report)J M Nunes, M E Riccio, S Buhler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related deathPhilippe Moreau, Michele Cavo, Pieter Sonneveld, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du MyélomeBruno Royer, Stéphane Minvielle, Momar Diouf, et al.Bone Marrow Transplantation|February 9, 2016
Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHIT Cluzeau, J Lambert, N Raus, et al.Leukemia|May 24, 2018
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroupsNiccolo Bolli, Giulia Biancon, Matahi Moarii, et al.Plos Biology|October 30, 2025
eDNA surveys substantially expand known geographic and ecological niche boundaries of marine fishesLoïc Sanchez, Nicolas Loiseau, Camille Albouy, et al.Leukemia|April 23, 2010
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementR A Kyle, B G M Durie, S V Rajkumar, et al.Blood|November 14, 2022
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factorAnaïs Schavgoulidze, Alexis Talbot, Aurore Perrot, et al.The French Journal of Urology|July 1, 2026
Patient-reported health and quality of life after midurethral sling: a comparative analysis from VIGI-MESH registryXavier Fritel, Léa Mauny, Camille Armengaud, et al.Pageof 188